Chromatin accessibility trajectories reveal pre-cancerous epigenetic priming and an acid-driven immunotherapy-resistant gastric cancer subtype
Cancer Cell · 2026-11 · 44 (11) · 2189-2207.e18
DOI: 10.1016/j.ccell.2026.09.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2026-11. Verfasst von Tao Wang und 43 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University, Chongqing 400042, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Epigenesis, Genetic, Drug Resistance, Neoplasm, Immunotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 117 Literaturangaben.
Abstract (Originalsprache)
Chromatin remodeling is prominent in cancers, yet it remains obscure how chromatin dynamics underlies stepwise tumorigenesis and informs anti-cancer therapeutics. By decoding a large-scale chromatin accessibility atlas of 650 multistage samples from 439 patients, we delineate epigenetic switches spanning multistep gastric tumorigenesis. A cancer-resembling epigenetic priming state in intestinal metaplasia licenses subsequent tumor initiation. In advanced malignancies, inter-tumoral diversity stratifies three epigenomic subtypes. The proliferative and mesenchymal-inflammatory subtypes are sensitive to neoadjuvant immunotherapy, while the pseudo-gastric subtype is intrinsically drug resistant. Mechanistically, the refractory subtype is featured by a unique gastric lineage-mimicking phenotype, governed in part by FOSL2 to up-regulate H+/K+ ATPase transporters and sculpt an acidic milieu suppressing CD8+ T cells. Inhibition of this phenotype by either FOSL2 depletion or vonoprazan, a clinically available acid blocker, sensitizes immunotherapy. Collectively, these findings highlight that chromatin accessibility dynamics facilitates sequential tumorigenesis from gastric pre-cancer and defines subtypes exploitable to guide immunotherapy and overcome drug resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University, Chongqing 400042, China.
- Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University, Chongqing 400042, China; Jinfeng Laboratory, Chongqing 401329, China; Department of Oncology,…
- Biomedical Pioneering Innovation Center (BIOPIC), Peking-Tsinghua Center for Life Sciences, State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, School of Life Sciences, Pekin…
- Jinfeng Laboratory, Chongqing 401329, China; College of Sericulture, Textile and Biomass Sciences, Southwest University, Chongqing 400716, China.
- Department of Oncology, Fuling Hospital of Traditional Chinese Medicine, Chongqing University of Chinese Medicine, Chongqing 408000, China.
- Department of Immunology, College of Basic Medicine, Army Medical University, Chongqing 400038, China.
Zitieren
APA
Wang, T., Xiang, J., Tian, S., Wang, X., Chu, Z., Yang, Z., Gao, W., Li, X., Liu, B., Ma, Q., Lei, Z., Shen, X., Zhou, Y., Wang, L., Wan, L., Zheng, Q., Liu, W., Li, J., Wu, L., …, & Wang, B. (2026). Chromatin accessibility trajectories reveal pre-cancerous epigenetic priming and an acid-driven immunotherapy-resistant gastric cancer subtype. Cancer Cell, 44(11), 2189-2207.e18. https://doi.org/10.1016/j.ccell.2026.09.004
Vancouver
Wang T, Xiang J, Tian S, Wang X, Chu Z, Yang Z, et al. Chromatin accessibility trajectories reveal pre-cancerous epigenetic priming and an acid-driven immunotherapy-resistant gastric cancer subtype. Cancer Cell. 2026;44(11):2189-2207.e18. doi:10.1016/j.ccell.2026.09.004
BibTeX
@article{Wang2026,
author = {Wang, Tao and Xiang, Junyu and Tian, Shuoran and Wang, Xiangming and Chu, Zhaole and Yang, Zailiang and Gao, Weiwu and Li, Xianfeng and Liu, Biying and Ma, Qiang and Lei, Zengjie and Shen, Xiaochun and Zhou, Yinbin and Wang, Lei and Wan, Linghong and Zheng, Quanyou and Liu, Wenkang and Li, Jinyang and Wu, Linyu and Hou, Yongying and Zheng, Xipeng and Pan, Huilin and Qin, Shixin and Liu, Qin and Sun, Mengting and Chen, Xu and Tian, Fanxuan and Hu, Xiao and Peng, Ziyi and Zhong, Zhaoyang and Chen, Chuan and Li, Fan and Wang, Shunan and Chen, Dongfeng and Wen, Liangzhi and Li, Ke and Zhang, Qiaoqiao and Lin, Cheng and Qin, Zhongyi and Miao, Zhifeng and Bian, Xiu-Wu and Wang, Zhenning and Bai, Fan and Wang, Bin},
title = {Chromatin accessibility trajectories reveal pre-cancerous epigenetic priming and an acid-driven immunotherapy-resistant gastric cancer subtype},
journal = {Cancer Cell},
year = {2026},
volume = {44},
number = {11},
pages = {2189--2207.e18},
doi = {10.1016/j.ccell.2026.09.004}
}
EUVIMED